Toll-like receptor 2 is dispensable for acquired host immune resistance to Candida albicans in a murine model of disseminated candidiasis

Microbes and Infection

Volumn 6, Issue 6, 2004, Pages 542-548

  Villamón, Eva ^a   Gozalbo, Daniel ^a   Roig, Patricia ^a   O'Connor, José Enrique ^a   Ferrandiz, M Luisa ^a   Fradelizi, Didier ^b   Gil, M Luisa ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b INSTITUT COCHIN   (France)

Author keywords

Candida albicans; IFN ; IL 12; Specific antibodies; TLR2; TNF ; Vaccination

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPERIMENTAL INFECTION; FUNGAL STRAIN; FUNGAL VIRULENCE; GENE DELETION; HOST RESISTANCE; HUMORAL IMMUNITY; IMMUNOREACTIVITY; INFECTION RESISTANCE; INFECTION RISK; LETHALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REINFECTION; TH1 CELL; VACCINATION; WILD TYPE;

ANIMALS; ANTIBODIES, FUNGAL; CANDIDA ALBICANS; CANDIDIASIS; CYTOKINES; IMMUNITY, NATURAL; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-12; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, CELL SURFACE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

CANDIDA; CANDIDA ALBICANS; FUNGI; MURINAE;

EID: 2542504652     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2004.02.015     Document Type: Article

References (38)

1. Calderone R.A. Candida and candidiasis. 2001;ASM Press, New York
2. Garber G. An overview of fungal infections. Drugs. 61:(Suppl. 1):2001;1-12
3. Romani L. Innate and adaptive immunity in Candida albicans infections and saprophytism. J. Leukoc. Biol. 68:2000;175-179
4. Puccetti P., Romani L., Bistoni F. A Th1-Th2-like switch in candidiasis; new perspectives for therapy. Trends Microbiol. 3:1995;237-240
5. Kaposzta R., Tree P., Marodi L., Gordon S. Characterization of invasive candidiasis in gamma interferon- and interleukin-4-deficient mice: role of macrophages in host defense against Candida albicans. Infect. Immun. 66:1998;1708-1717
6. Nisini R., Romagnoli G., Gomez M.J., La Valle R., Torosantucci A., Mariotti S., Teloni R., Cassone A. Antigenic properties and processing requirements of a 65-kilodalton mannoprotein, a major antigen target of anti-Candida human T-cell response, as disclosed by specific human T-cell clones. Infect. Immun. 69:2001;3728-3736
7. Menacci A., Cenci E., Del Sero G., Fe d'Ostiani C., Mosci P., Trinchieri G., Adorini L., Romani L. IL-10 is required for development of protective Th1 response in IL-12-deficient mice upon Candida albicans infection. J. Immunol. 161:1998;6228-6237
8. Menacci A., Del Sero G., Cenci E., Fe d'Ostiani C., Bacci A., Montagnoli C., Kopf M., Romani L. Endogenous interleukin 4 is required for development of protective CD4+ T helper type 1 cell responses to Candida albicans. J. Exp. Med. 187:1998;307-317
9. Montagnoli C., Bacci A., Bozza S., Gaziano R., Mosci P., Sharpe A.H., Romani L. B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J. Immunol. 169:2002;6298-6308
10. Montagnoli C., Bozza S., Bacci A., Gaziano R., Mosci P., Morschhauser J., Pitzurra L., Kopf M., Cutler J., Romani L. A role for antibodies in the generation of memory antifungal immunity. Eur. J. Immunol. 33:2003;1193-1204
11. Takeda K., Kaisho T., Akira S. Toll-like receptors. Ann. Rev. Immunol. 21:2003;335-376
12. Kopp E., Medzhitov R. Recognition of microbial infection by toll-like receptors. Curr. Opin. Immunol. 15:2003;396-401
13. Barton G.M., Medzhitov R. Control of adaptive immune responses by toll-like receptors. Curr. Opin. Immunol. 14:2002;380-383
14. Roeder A., Kirschning C.J., Rupec R.A., Schaller M., Korting H.C. Toll-like receptors and innate antifungal responses. Trends Microbiol. 12:2004;44-49
15. Villamón E., Gozalbo D., Roig P., O'Connor J.E., Fradelizi D., Gil M.L. Toll-like receptor 2 is essential in murine defenses against Candida albicans infections. Microb. Infect. 6:2004;1-7
16. Jouault T., Ibata-Ombetta S., Takeuchi O., Trinel P.A., Sacchetti P., Lefebvre P., Akira S., Poulain D. Candida albicans phospholipomannan is sensed through toll-like receptors. J. Infect. Dis. 188:2003;165-172
17. Netea M.G., Van der Graaf C.A.A., Vonk A.G., Verschueren I., Van der Meer J.W.M., Kullberg B.J. The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J. Infect. Dis. 185:2002;1483-1489
18. Cenci E., Romani L., Vecchiarelli A., Puccetti P., Bistoni F. Role of L3T4+ lymphocytes in protective immunity to systemic Candida albicans infection in mice. Infect. Immun. 57:1989;3581-3587
19. Cenci E., Romani L., Vecchiarelli A., Puccetti P., Bistoni F. T cell subsets and IFN-γ production in resistance to systemic candidosis in immunized mice. J. Immunol. 144:1990;4333-4339
20. Romani L., Mocci S., Cenci E., Rossi R., Puccetti P., Bistoni F. Candida albicans-specific Lyt-2+ lymphocytes with cytolytic activity. Eur. J. Immunol. 21:1991;1567-1570
21. Romani L., Mocci S., Bietta C., Lanfaloni L., Puccetti P., Bistoni F. Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance. Infect. Immun. 59:1991;4647-4654
22. Romani L., Mencacci A., Cenci E., Mosci P., Vitellozzi G., Grohmann U., Puccetti P., Bistoni B. Course of primary candidiasis in T-cell depleted mice infected with attenuated variant cells. J. Infect. Dis. 166:1992;1384-1392
23. Romani L., Mencacci A., Cenci E., Spaccapelo R., Mosci P., Puccetti P., Bistoni F. CD4+ subset expression in murine candidiasis. J. Immunol. 150:1993;925-931
24. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., Takeda K., Akira S. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity. 11:1999;443-451
25. De Bernardis F., Adriani F.D., Lorenzini R., Pontieri E., Carruba G., Cassone A. Filamentous growth and elevated vaginopathic potential of a non-germinative variant of Candida albicans expressing low virulence in systemic infection. Infect. Immun. 61:1993;1500-1508
26. Gil-Navarro I., Gil M.L., Casanova M., O'Connor J.E., Martínez J.P., Gozalbo D. The glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase of Candida albicans is a surface antigen. J. Bacteriol. 179:1997;4992-4999
27. Gozalbo D., Gil-Navarro I., Azorín I., Renau-Piqueras J., Martínez J.P., Gil M.L. The cell wall-associated glyceraldehyde-3- phosphate dehydrogenase of Candida albicans is also a fibronectin and laminin binding protein. Infect. Immun. 66:1998;2052-2059
28. Chiani P., Bromuro C., Torosantucci A. Defective induction of interleukin-12 in human monocytes by germ-tube forms of Candida albicans. Infect. Immun. 68:2000;5628-5634
29. Liu L., Kang K., Takahara M., Cooper K.D., Ghannoum M.A. Hyphae and yeasts of Candida albicans differentially regulate interleukin-12 production by human blood monocytes: inhibitory role of C. albicans germination. Infect. Immun. 69:2001;4695-4697
30. Fe d'Ostiani C., Del Sero G., Bacci A., Montagnoli C., Spreca A., Mencacci A., Ricciardi-Castagnoli P., Romani L. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans: implications for initiation of T helper cell immunity in vitro and in vivo. J. Exp. Med. 191:2000;1661-1673
31. Romani L., Montagnoli C., Bozza S., Perruccio K., Spreca A., Allavena P., Verbeek S., Calderone R.A., Bistoni F., Puccetti P. The exploitation of distinct recognition receptors in dendritic cells determines the full range of host-immune relationships with Candida albicans. Int. Immunol. 16:2004;149-161
32. Netea M.G., Block W.L., Kullerg B.J., Bemelmans M., Vogels M.T.E., Buurman W.A., Van der Meer J.W.M. Pharmacological inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice. J. Infect. Dis. 171:1995;393-399
33. Steinshamn S., Waage A. Tumor necrosis factor and interleukin-6 in Candida albicans infection in normal and granulocytopenic mice. Infect. Immun. 60:1992;4003-4008
34. Netea M.G., Van Tits L.J.H., Curfs J.H.A.J., Amiot F., Meis J.F.G.M., Van der Meer J.W.M., Kullberg B.J. Increased susceptibility of TNF-α lymphotoxin-α double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida. J. Immunol. 163:1999;1498-1505
35. Steinshamn S., Bemelmans M.H.A., Van Tits L.H.J., Bergh K., Buurman W.A., Waage A. TNF receptors in murine Candida albicans infection: evidence for an important role of TNF receptor p55 in antifungal defense. J. Immunol. 157:1996;2155-2159
36. Han Y., Cutler J.E. Antibody response that protects against disseminated candidiasis. Infect. Immun. 63:1998;2714-2719
37. Bromuro C., Torosantucci A., Chiani P., Conti S., Polonelli L., Cassone A. Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated candidiasis in recipients of Candida albicans vaccine. Infect. Immun. 70:2002;5462-5470
38. Matthews R., Burnie J. Antifungal antibodies: a new approach to the treatment of systemic candidiasis. Curr. Opin. Investig. Drugs. 2:2001;472-476